Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Clinical Relevance of the babA2 Genotype of Helicobacter pylori in Japanese Clinical Isolates

Takuji Mizushima, Toshiro Sugiyama, Yoshito Komatsu, Jun Ishizuka, Mototsgu Kato, Masahiro Asaka
Takuji Mizushima
Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo 060-8638, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiro Sugiyama
Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo 060-8638, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshito Komatsu
Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo 060-8638, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Ishizuka
Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo 060-8638, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mototsgu Kato
Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo 060-8638, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahiro Asaka
Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo 060-8638, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.39.7.2463-2465.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Genotypic variation of Helicobacter pylori is speculated to associate with different clinical outcomes. In Western countries, the gene encoding blood group antigen-binding adhesin (BabA), babA2, is of high clinical relevance and is a useful marker to identify patients who are at higher risk for peptic ulceration and gastric adenocarcinoma, as are vacA andcagA. We investigated the presence of babA2 andcagA in 179 Japanese clinical isolates by PCR and Southern blot analysis and looked for correlations with various clinical outcomes (nonulcer dyspepsia, duodenal ulcers, gastric ulcers gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma). The prevalence of the babA2 genotype was 84.9% and that of thecagA genotype was 96.1%. There was no correlation between the babA2 and cagA genotypes, and there was no association between the babA2 or cagA status and clinical outcome. These results indicate that babA2status is not of high clinical relevance in Japan and that Japanese strains are different from those infecting Western populations.

Helicobacter pyloriinfection in the stomach activates a mucosal inflammatory response and leads to diverse clinical outcomes in humans (3). Most infected persons are asymptomatic with histologic gastritis (22), or they may develop a gastric or duodenal ulcer (1), adenocarcinoma (13), or mucosa-associated lymphoid tissue (MALT) lymphoma (27, 32) of the stomach.

Numerous studies indicate that both bacterial and host factors may be important in leading to particular clinical and pathological sequelae of the infection. Among the bacterial factors, the role of the ability to adhere to epithelial cells is crucial in the initiation of a gastric inflammatory response (17, 24, 28). The blood group antigen-binding adhesin BabA has been shown to mediate adherence ofH. pylori to human Lewis b (α-1,3/4-difucosylated) blood group antigens on gastric epithelial cells (5). In vitro adherence assays revealed that H. pylori bound in a lineage-specific manner to gastric surface mucous cells mediated by fucosylated blood group antigens (11). Furthermore, a study using transgenic mice expressing the human Lewis b epitope in gastric epithelial cells indicated that Lewis b antigens function as receptors for an H. pylori adhesin and mediate its attachment to gastric pit and surface mucous cells (12). The attachment of H. pylori to gastric epithelial cells in such transgenic mice resulted in the development of chronic gastritis and gastric atrophy (15). In a recent study, the gene encoding BabA was cloned (and named babA2), thus allowing the identification of H. pylori strains harboring thebabA2 genotype by PCR (18).

The cag pathogenicity island is one of the major virulence factors of H. pylori, and there is a high frequency of the presence of the cagA gene in the cagpathogenicity island in patients with duodenal ulcers (16), atrophic gastritis (21, 22), gastric carcinomas (4), and MALT lymphomas (9) in Western countries. However, in Japan H. pylori strains harboring the cagA gene have not been related to clinical outcomes because of the very high prevalence of strains harboring thecagA gene in Japanese clinical isolates (25, 29). A recent study has shown that the presence of thebabA2 gene was significantly associated with duodenal ulcers and gastric carcinomas and with the presence of the cagAgenotype in a Western population (14).

The clinical relevance of the H. pylori babA2 genotype has not yet been determined in a large series of clinical isolates in Japan. Therefore, we investigated the presence of babA2 andcagA in Japanese clinical H. pylori isolates and their correlation with clinical outcomes (nonulcer dyspepsia, duodenal ulcer, gastric ulcer, gastric adenocarcinoma, and MALT lymphoma).

MATERIALS AND METHODS

Subjects.One hundred seventy-nine H. pyloristrains were obtained from antral and corpus biopsies from Japanese patients between 1997 and 1999 at Hokkaido University Hospital, Sapporo, Japan. None of the patients had received nonsteroidal antiinflammatory drugs or antibiotics within the previous 3 months. The patient population consisted of 179 patients (117 men and 62 women) with a mean age of 48.6 years (range, 21 to 74 years). The patients were classified at the time of endoscopy into those having gastric ulcers (n = 45) , duodenal ulcers (n = 41) , gastric adenocarcinomas (n = 40) , MALT lymphomas (n = 11) , or no evidence of mucosal ulceration but with chronic gastritis (nonulcer dyspepsias) (n = 42) . The classification of patients was based on the results of endoscopic and histological examinations.

Bacterial strains.Biopsy specimens were cultured onH. pylori-selective agar plates (Eiken Chemical Co., Ltd., Tokyo, Japan) under microaerophilic conditions (5% O2, 10% CO2, 85% N2 at 37°C; AaeroPack Systems, Mitsubishi Gas Chemical, Osaka, Japan) for up to 5 days. The organisms were identified as H. pylori by Gram staining, colony morphology, and positive oxidase, catalase, and urease reactions. A single colony on the agar was collected and cultured again under the same microaerophilic conditions in brain heart infusion broth (Nissui, Osaka, Japan) containing 5% (vol/vol) horse serum for up to 3 days. Aliquots were stored at −80°C in 10% phosphate-buffered saline containing 20% (vol/vol) glycerol. After thawing of the aliquots of the frozen culture, bacterial suspensions were cultured at 37°C in brain heart infusion broth containing 5% fetal calf serum (GIBCO BRL, Rockville, Md.) under microaerobic conditions as described above on a gyratory shaker at 160 rpm for 24 to 36 h to the plateau phase. The bacterial suspensions were centrifuged at 2,000 × g for 5 min, and the bacterial pellets were used for genomic DNA extraction. Genomic DNA was extracted by using a SepaGene kit (Nippon Gene, Toyama, Japan) according to the manufacturer's instructions.

PCR.PCR was performed according to a previously reported method (2). An aliquot (0.5 μl) of Taq DNA polymerase and deoxynucleoside triphosphates (Takara Shuzou Co., Ltd., Shiga, Japan) was mixed with 1 μl of a genomic DNA sample of each strain and primer. The babA2 primers were designed on the basis of the recently published signal sequence of the babA2gene (14). The primers used were babA2F (5′-AATCCAAAAAGGAGAAAAAGTATGAAA-3′) and babA2R (5′-TGTTAGTGATTTCGGTGTAGGACA-3′) for babA2amplification, ureAF (5′-GCCAATGGTAAATTAGTT-3′) and ureAR (5′-CTCCTTAATTGTTTTTAC-3′) forureA amplification, and cagAF (5′-GGGGATCCATGACTAACGAAACC-3′) and cagAR (5′-GGCTTAAGTGATGGGACACCCAA-3′) for cagAamplification. These base sequences corresponded to the nucleotide sequences of strain NTCC 11638 or strain J99 (31). PCR was performed using a thermal cycler (Takara Shuzou) under the following conditions: an initial denaturation for 5 min at 92°C; 35 cycles of 1 min at 92°C, 1 min at 52 to 58°C, and 1 min at 72°C; and a final extension at 72°C for 10 min. PCR amplification of the H. pylori ureA gene was performed as a positive control.

Southern blot analysis.Ten micrograms of genomic DNA ofH. pylori was digested by the restriction enzymeMboII (New England BioLabs, Beverly, Mass.), electrophoresed on a 1% agarose gel, and then transferred onto a nylon membrane. ThecagA probe was made from the same primers as those described above and labeled with digoxigenin (DIG) using a PCR DIG probe synthesis kit (Boehringer Mannheim GmbH, Mannheim, Germany). ThecagA probe was located in the upstream region of the totalcagA gene (381 of 4,043 bp). These base sequences corresponded to the nucleotide sequences of the cagA gene of strain NTCC 11638. The membrane was hybridized with the labeled probe for 20 h at 42°C in DIG Easy Hyb (Boehringer Mannheim GmbH). After being washed sequentially in 2× SSC–0.1% sodium dodecyl sulfate (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and 0.2× SSC–0.1% sodium dodecyl sulfate, the detection of the membrane was done by using a DIG nucleic acid detection kit (Boehringer Mannheim GmbH) according to the manufacturer's instructions.

Statistical analysis.Fisher's exact test was used for the analysis of categorical data (Table 1). Analyses were done using Stat View Software, version 4.5 (SAS Institute Inc., Cary, N.C.). A P value of <0.05 was accepted as statistically significant.

View this table:
  • View inline
  • View popup
Table 1.

Correlation between the babA2 andcagA genotypes and disease prevalence

RESULTS

PCR and Southern blot analysis.The babA2 genotype was detected in 152 of the 179 isolates (84.9%) by PCR. ThecagA genotype was detected in 172 of the 179 isolates (96.1%) by PCR and Southern blot analysis. ThebabA2-positive strains showed the presence ofcagA (146 of 152 isolates [96.7%]). Twenty-six of the 27babA2-negative strains showed the presence ofcagA (96.3%). Only one of the 27 babA2-negative strains (3.7%) did not show the presence of cagA. There was no correlation between the babA2 genotype and thecagA genotype.

Relationship between prevalence of cagA andbabA2 genotypes and clinical outcome.Table 1 shows the relationship between the prevalence of the cagA andbabA2 genotypes and clinical outcome. The overall prevalence of the babA2 genotype was 84.9% (152 of 179 isolates). No significant correlation was obtained between the babA2genotype and clinical outcome.

The overall prevalence of the cagA genotype was 96.1% (172 of 179 isolates). The presence of the cagA genotype was not correlated with any clinical outcomes (Table 1).

DISCUSSION

The adherence of H. pylori to epithelial cells is a crucial factor in the specific tropism and pathogenicity of the organism in the stomach (4, 16, 17, 24, 28). Biochemical studies have identified a protein from H. pylori, an adhesin named BabA, that allows binding to the blood group antigen Lewis b present on the surface of gastric epithelial cells (6). Two corresponding genes encoding BabA have been cloned and namedbabA1 and babA2 (18). Only thebabA2 gene is functionally active (18). These two genes have almost complete sequence homology, with the exception of a translational initiation codon in the signal peptide sequence found only in babA2 (18). A recent study has shown that a mismatch PCR method that amplifies the signal peptide sequence is an efficient method for selective identification of the presence of the babA2 gene (14). The distribution of the presence of the babA2 genotype in Western countries has been shown to be about 66 to 72% in recent studies (14, 18). One of these studies has suggested that the presence of babA2, vacAs1, and cagA (“triple-positive” strains) showed a highly significant correlation to the prevalence of duodenal ulcers and gastric adenocarcinomas (14). Although a previous study in Japan showed that almost all Japanese strains (97.7%) harbored the vacAs1 genotype (19), we tested for the presence of the vacAs1 genotype by PCR (19). In our study, it was confirmed that 172 of 179 strains (96.1%) showed the vacAs1 genotype. In addition, there was no correlation between the babA2 andvacAs1 genotypes (data not shown).

The present study suggested that the prevalence of the babA2genotype is higher in Japan than in Western countries and that there is not a significant correlation between the babA2 genotype and clinical outcome in Japan. These results are not in accordance with those of a recent study in a Western population (14). In Japan, only a few patients infected with babA2-, cagA-, orvacAs1-positive strains will suffer from peptic ulcers or gastric adenocarcinomas. It is therefore difficult to explain the different clinical outcomes from virulence factors only, such asbabA2, cagA, and vacAs1 of H. pylori.

We tested the adherence abilities of babA2-negative strains compared with those of babA2-positive strains in an in vitro study in which a flow-cytometric assay was performed by using Lewis b-positive gastric epithelial cells (KATOIII cells). Our findings showed that the babA2-positive strains adhered more strongly than did the babA2-negative strains but that thebabA2-negative strains adhered weakly to the cells (data not shown). It is still a fact that both the babA2-positive strains and the babA2-negative strains colonize in the stomach and that there are adherence factors other than thebabA2 gene. We therefore investigated the presence of thehpaA gene, one of the bacterial adhesins (8, 10, 17, 23, 26), in babA2-negative strains by PCR. ThehpaA gene was found to be present in allbabA2-negative strains (data not shown). We speculate that the babA2-negative strains can colonize in the human stomach because of the presence of other bacterial adhesins.

An explanation of the different clinical outcomes from the host factors, including histopathology of Lewis b expression in gastric tissue, may be possible, but a previous study in Japan showed that the majority of gastric biopsies from patients (95% of cases of normal foveolar epithelium, 75% of intestinal metaplasias, and 75% of intestinal types of gastric cancer) expressed Lewis b (20), and other previous studies in Western countries showed that the expression of the Lewis b antigen on primary gastric cells was about 95% (7, 30). One of those studies demonstrated that adherence of H. pylori to gastric epithelial cells was not dependent on the expression of either Lewis a or Lewis b on primary cells isolated from the biopsy and that incubation of primary gastric cells with monoclonal antibodies to either Lewis a or Lewis b had no effect on H. pylori binding (7). Thus, it seems to be difficult to explain the different clinical outcomes in Japan in terms of host factors such as the expression of Lewis b antigen on gastric epithelial cells and the presence of BabA.

In conclusion, our current data do not support the hypothesis that the virulence factors of H. pylori, BabA and CagA, are strongly associated with peptic ulcer disease and gastric adenocarcinoma in Western countries. We speculate that the prevalences ofbabA2 and cagA genotypes in Japan are much higher than those in Western countries.

ACKNOWLEDGMENTS

This study was supported in part by a grant-in-aid for scientific research from the Japanese Ministry of Education, Science, Sports, and Culture (to T.S. and M.A.) and by a grant-in-aid for cancer research from the Japanese Ministry of Health and Welfare (to T.S.).

FOOTNOTES

    • Received 16 January 2001.
    • Returned for modification 23 March 2001.
    • Accepted 7 May 2001.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    Anonymous NIH consensus conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease.JAMA27219946569
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Awakawa T.,
    2. Sugiyama T.,
    3. Hisano K.,
    4. Karita M.,
    5. Yachi A.
    Detection and identification of cagA of Helicobacter pylori by polymerase chain reaction.Eur. J. Gastroenterol. Hepatol.71995S75S78
    OpenUrl
  3. 3.↵
    1. Blaser M. J.
    Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation.Gastroenterology1021992720727
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Blaser M. J.,
    2. Perez-Perez G. I.,
    3. Kleanthous H.,
    4. Cover T. L.,
    5. Peek R. M.,
    6. Chyou P. H.,
    7. Stemmermann G. N.,
    8. Nomura A.
    Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.Cancer Res.55199521112115
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Boren T.,
    2. Falk P.,
    3. Roth K. A.,
    4. Larson G.,
    5. Normark S.
    Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens.Science262199318921895
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Boren T.,
    2. Normark S.,
    3. Falk P.
    Helicobacter pylori: molecular basis for host recognition and bacterial adherence.Trends Microbiol.21994221228
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Clyne M.,
    2. Drumm B.
    Absence of effect of Lewis A and Lewis B expression on adherence of Helicobacter pylori to human gastric cells.Gastroenterology11319977280
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Doig P.,
    2. Austin J. W.,
    3. Kostrzynska M.,
    4. Trust T. J.
    Production of a conserved adhesin by the human gastroduodenal pathogen Helicobacter pylori.J. Bacteriol.174199225392547
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Eck M.,
    2. Schmausser B.,
    3. Haas R.,
    4. Greiner A.,
    5. Czub S.,
    6. Muller-Hermelink H. K.
    MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein.Gastroenterology112199714821486
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Evans D. G.,
    2. Evans D. J. Jr.,
    3. Moulds J. J.,
    4. Graham D. Y.
    N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen.Infect. Immun.56198828962906
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Falk P. G.,
    2. Roth K. A.,
    3. Boren T.,
    4. Westblom T. U.,
    5. Gordon J. I.,
    6. Normark S.
    An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium.Proc. Natl. Acad. Sci. USA90199320352039
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Falk P. G.,
    2. Bry L.,
    3. Holgersson J.,
    4. Gordon J. I.
    Expression of a human alpha-1, 3/4-fucosyltransferase in the pit cell lineage of FVB/N mouse stomach results in production of Leb-containing glycoconjugates: a potential transgenic mouse model for studying Helicobacter pylori infection.Proc. Natl. Acad. Sci. USA92199515151519
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Forman D.,
    2. Newell D. G.,
    3. Fullerton F.,
    4. Yarnell J. W.,
    5. Stacey A. R.,
    6. Wald N.,
    7. Sitas F.
    Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.BMJ302199113021305
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Gerhard M.,
    2. Lehn N.,
    3. Neumayer N.,
    4. Boren T.,
    5. Rad R.,
    6. Schepp W.,
    7. Miehlke S.,
    8. Classen M.,
    9. Prinz C.
    Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin.Proc. Natl. Acad. Sci. USA9619991277812783
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Guruge J. L.,
    2. Falk P. G.,
    3. Lorenz R. G.,
    4. Dans M.,
    5. Wirth H. P.,
    6. Blaser M. J.,
    7. Berg D. E.,
    8. Gordon J. I.
    Epithelial attachment alters the outcome of Helicobacter pylori infection.Proc. Natl. Acad. Sci. USA95199839253930
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Hamlet A.,
    2. Thoreson A. C.,
    3. Nilsson O.,
    4. Svennerholm A. M.,
    5. Olbe L.
    Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers.Gastroenterology1161999259268
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Hessey S. J.,
    2. Spencer J.,
    3. Wyatt J. I.,
    4. Sobala G.,
    5. Rathbone B. J.,
    6. Axon A. T.,
    7. Dixon M. F.
    Bacterial adhesion and disease activity in Helicobacter-associated chronic gastritis.Gut311990134138
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Ilver D.,
    2. Arnqvist A.,
    3. Ogren J.,
    4. Frick I. M.,
    5. Kersulyte D.,
    6. Incecik E. T.,
    7. Berg D. E.,
    8. Covacci A.,
    9. Engstrand L.,
    10. Boren T.
    Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging.Science2791998373377
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Ito Y.,
    2. Azuma T.,
    3. Ito S.,
    4. Miyaji H.,
    5. Hirai M.,
    6. Yamazaki Y.,
    7. Sato F.,
    8. Kato T.,
    9. Kohli Y.,
    10. Kuriyama M.
    Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan.J. Clin. Microbiol.35199717101714
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Kobayashi K.,
    2. Sakamoto J.,
    3. Kito T.,
    4. Yamamura Y.,
    5. Koshikawa T.,
    6. Fujita M.,
    7. Watanabe T.,
    8. Nakazato H.
    Lewis blood group-related antigen expression in normal gastric epithelium, intestinal metaplasia, gastric adenoma, and gastric carcinoma.Am. J. Gastroenterol.881993919924
    OpenUrlPubMedWeb of Science
  21. 21.↵
    1. Kuipers E. J.,
    2. Perez-Perez G. I.,
    3. Meuwissen S. G.,
    4. Blaser M. J.
    Helicobacter pylori and atrophic gastritis: importance of the cagA status.J. Natl. Cancer Inst.87199517771780
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Kuipers E. J.,
    2. Uyterlinde A. M.,
    3. Pena A. S.,
    4. Roosendaal R.,
    5. Pals G.,
    6. Nelis G. F.,
    7. Festen H. P.,
    8. Meuwissen S. G.
    Long-term sequelae of Helicobacter pylori gastritis.Lancet345199515251528
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Lingwood C. A.,
    2. Wasfy G.,
    3. Han H.,
    4. Huesca M.
    Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori.Infect. Immun.61199324742478
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Logan R. P.
    Adherence of Helicobacter pylori.Aliment. Pharmacol. Ther.101996S3S15
    OpenUrl
  25. 25.↵
    1. Maeda S.,
    2. Ogura K.,
    3. Yoshida H.,
    4. Kanai F.,
    5. Ikenoue T.,
    6. Kato N.,
    7. Shiratori Y.,
    8. Omata M.
    Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan.Gut421998338343
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Odenbreit S.,
    2. Till M.,
    3. Hofreuter D.,
    4. Faller G.,
    5. Haas R.
    Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue.Mol. Microbiol.31199915371548
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Parsonnet J.,
    2. Hansen S.,
    3. Rodriguez L.,
    4. Gelb A. B.,
    5. Warnke R. A.,
    6. Jellum E.,
    7. Orentreich N.,
    8. Vogelman J. H.,
    9. Friedman G. D.
    Helicobacter pylori infection and gastric lymphoma.N. Engl. J. Med.330199412671271
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Segal E. D.,
    2. Falkow S.,
    3. Tompkins L. S.
    Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins.Proc. Natl. Acad. Sci. USA93199612591264
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Shimoyama T.,
    2. Fukuda S.,
    3. Tanaka M.,
    4. Mikami T.,
    5. Saito Y.,
    6. Munakata A.
    High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients.Scand. J. Gastroenterol.321997465468
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Taylor D. E.,
    2. Rasko D. A.,
    3. Sherburne R.,
    4. Ho C.,
    5. Jewell L. D.
    Lack of correlation between Lewis antigen expression by Helicobacter pylori and gastric epithelial cells in infected patients.Gastroenterology115199811131122
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Tomb J. F.,
    2. White O.,
    3. Kerlavage A. R.,
    4. Clayton R. A.,
    5. Sutton G. G.,
    6. Fleischmann R. D.,
    7. Ketchum K. A.,
    8. Klenk H. P.,
    9. Gill S.,
    10. Dougherty B. A.,
    11. Nelson K.,
    12. Quackenbush J.,
    13. Zhou L.,
    14. Kirkness E. F.,
    15. Peterson S.,
    16. Loftus B.,
    17. Richardson D.,
    18. Dodson R.,
    19. Khalak H. G.,
    20. Glodek A.,
    21. McKenney K.,
    22. Fitzegerald L. M.,
    23. Lee N.,
    24. Adams M. D.,
    25. Gocayne J. D.,
    26. Utterback T. R.,
    27. Peterson J. D.,
    28. Kelley J. M.,
    29. Cotton M. D.,
    30. Weidman J. M.,
    31. Fujii C.,
    32. Bowman C.,
    33. Watthey L.,
    34. Wallin E.,
    35. Hayes W. S.,
    36. Borodovsky M.,
    37. Karp P. D.,
    38. Smith H. O.,
    39. Fraser C. M.,
    40. Hickey K.,
    41. Berg D. E.,
    42. Venter J. C.
    The complete genome sequence of the gastric pathogen Helicobacter pylori.Nature3881997539547
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Wotherspoon A. C.,
    2. Ortiz-Hidalgo C.,
    3. Falzon M. R.,
    4. Isaacson P. G.
    Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.Lancet338199111751176
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Clinical Relevance of the babA2 Genotype of Helicobacter pylori in Japanese Clinical Isolates
Takuji Mizushima, Toshiro Sugiyama, Yoshito Komatsu, Jun Ishizuka, Mototsgu Kato, Masahiro Asaka
Journal of Clinical Microbiology Jul 2001, 39 (7) 2463-2465; DOI: 10.1128/JCM.39.7.2463-2465.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Relevance of the babA2 Genotype of Helicobacter pylori in Japanese Clinical Isolates
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinical Relevance of the babA2 Genotype of Helicobacter pylori in Japanese Clinical Isolates
Takuji Mizushima, Toshiro Sugiyama, Yoshito Komatsu, Jun Ishizuka, Mototsgu Kato, Masahiro Asaka
Journal of Clinical Microbiology Jul 2001, 39 (7) 2463-2465; DOI: 10.1128/JCM.39.7.2463-2465.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Adhesins, Bacterial
Antigens, Bacterial
Carrier Proteins
Helicobacter Infections
Helicobacter pylori
Stomach Diseases

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X